Vericel Corp. (VCEL)
57.42
-2.03
(-3.41%)
USD |
NASDAQ |
Nov 12, 16:00
57.40
-0.02
(-0.03%)
After-Hours: 20:00
Vericel Price to Book Value : 7.629 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.629 |
| November 11, 2026 | 7.899 |
| November 10, 2026 | 7.843 |
| November 09, 2026 | 7.758 |
| November 06, 2026 | 7.257 |
| November 05, 2026 | 6.880 |
| November 04, 2026 | 6.043 |
| November 03, 2026 | 5.460 |
| November 02, 2026 | 5.382 |
| October 30, 2026 | 5.349 |
| October 29, 2026 | 5.701 |
| October 28, 2026 | 5.460 |
| October 27, 2026 | 5.749 |
| October 26, 2026 | 5.719 |
| October 23, 2026 | 5.651 |
| October 22, 2026 | 5.709 |
| October 21, 2026 | 5.440 |
| October 20, 2026 | 5.392 |
| October 19, 2026 | 5.364 |
| October 16, 2026 | 5.332 |
| October 15, 2026 | 5.450 |
| October 14, 2026 | 5.348 |
| October 13, 2026 | 5.355 |
| October 12, 2026 | 5.397 |
| October 09, 2026 | 5.328 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.321 |
| October 07, 2026 | 5.413 |
| October 06, 2026 | 5.321 |
| October 05, 2026 | 5.457 |
| October 02, 2026 | 5.335 |
| October 01, 2026 | 5.240 |
| September 30, 2026 | 5.333 |
| September 29, 2026 | 5.616 |
| September 28, 2026 | 5.565 |
| September 25, 2026 | 5.491 |
| September 24, 2026 | 5.435 |
| September 23, 2026 | 5.364 |
| September 22, 2026 | 5.562 |
| September 21, 2026 | 5.469 |
| September 18, 2026 | 5.534 |
| September 17, 2026 | 5.536 |
| September 16, 2026 | 5.560 |
| September 15, 2026 | 5.493 |
| September 14, 2026 | 5.476 |
| September 11, 2026 | 5.302 |
| September 10, 2026 | 5.237 |
| September 09, 2026 | 5.392 |
| September 08, 2026 | 5.404 |
| September 04, 2026 | 5.558 |
| September 03, 2026 | 5.596 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.259 |
| Alnylam Pharmaceuticals, Inc. | 5.819 |
| Anika Therapeutics, Inc. | 1.344 |
| Savara, Inc. | 8.995 |
| Biogen, Inc. | 1.956 |
Price to Book Value Related Metrics
| PE Ratio | 90.87 |
| PS Ratio | 9.216 |
| PEG Ratio | 0.5595 |
| Price to Free Cash Flow | 51.60 |
| Price | 57.42 |
| Earnings Yield | 1.10% |
| Market Cap | 2.931B |
| PEGY Ratio | 0.5595 |
| Operating PE Ratio | 110.77 |
| Normalized PE Ratio | 90.88 |